Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma
- 29 April 2010
- journal article
- research article
- Published by Springer Nature in International Journal of Hematology
- Vol. 91 (5) , 808-819
Abstract
B cell-activating factor belonging to the tumor necrosis factor superfamily (BAFF) is a crucial factor for B cell development and is involved in the survival of malignant B cells, but its effect on B cell precursors (BCPs) remains unclear. We investigated BCP acute lymphoblastic leukemia (-ALL) cells for BAFF receptor (-R) expression and compared the effect of BAFF on BCP-ALL cells and Burkitt lymphoma (BL) cells. Expression of BAFF-R was detected in some cell lines and some clinical specimens of both BL and BCP-ALL. BAFF acted on both BL and BCP-ALL cells and promoted proliferation by both. BAFF also inhibited apoptosis by BL cells induced by cross-linking of cell surface molecules and anticancer drugs, but failed to inhibit apoptosis by BCP-ALL cells. BAFF induced prompt and obvious activation of the NF-κB signaling pathway in BL cells, but only weak and delayed activation of the pathway in BCP-ALL cells. The results of this study indicate that some BCP-ALL cells and some BL cells express BAFF-R, but that the effects of BAFF on BCP-ALL cells are different from its effects on mature B cell malignancies.Keywords
This publication has 43 references indexed in Scilit:
- B‐cell‐activating factor inhibits CD20‐mediated and B‐cell receptor‐mediated apoptosis in human B cellsImmunology, 2008
- Serum BAFF predicts prognosis better than APRIL in diffuse large B‐cell lymphoma patients treated with rituximab plus CHOP chemotherapyEuropean Journal of Haematology, 2008
- Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRILBlood, 2006
- Role of BAFF and APRIL in human B‐cell chronic lymphocytic leukaemiaImmunology, 2006
- Involvement of insulin-like growth factor-I and insulin-like growth factor binding proteins in pro–B-cell developmentExperimental Hematology, 2006
- Costimulatory signals distinctively affect CD20- and B-cell-antigen-receptor-mediated apoptosis in Burkitt's lymphoma/leukemia cellsLeukemia, 2003
- Granulocyte colony-stimulating factor directly affects human monocytes and modulates cytokine secretionExperimental Hematology, 2002
- Taci Is a Traf-Interacting Receptor for Tall-1, a Tumor Necrosis Factor Family Member Involved in B Cell RegulationJournal of Experimental Medicine, 2000
- Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell PopulationJournal of Experimental Medicine, 2000
- Characterization of the common acute lymphoblastic leukaemia antigen (CD10) as an activation molecule on mature human B cellsClinical and Experimental Immunology, 1990